Ting Therapeutics, Inc.
Publicly observedSan Diego, United States
Seen in a public record (e.g. a government grant database); not otherwise verified.
Details and provenance
| Item | Value | Source | Status |
|---|---|---|---|
| Country | US | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| City / locality | San Diego | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| Name | Ting Therapeutics, Inc. | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| UEI (U.S. federal entity ID) | F5R2ZH3HCHB5 | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
Recorded events
- Grant17 Jul 2020Publicly observed
NIH SBIR/STTR award: Therapeutics to prevent aminoglycoside-induced hearing loss
USD 524,299.00 · National Institute on Deafness and Other Communication Disorders · Source: NIH RePORTER (opens in a new tab)
- Grant17 Jul 2020Publicly observed
NIH SBIR/STTR award: Therapeutics to prevent aminoglycoside-induced hearing loss
USD 524,300.00 · National Institute on Deafness and Other Communication Disorders · Source: NIH RePORTER (opens in a new tab)
Information only — not investment advice or an endorsement. Is this your company? Submit or update its details or request a correction.